# Neoadjuvant Weekly Ixabepilone for High Risk, Clinically Localized Prostate Cancer

> **NCT00828308** · PHASE2 · COMPLETED · sponsor: **Brown University** · enrollment: 16 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** Ixabepilone
- **PROCEDURE:** Prostatectomy

## Key facts

- **NCT ID:** NCT00828308
- **Lead sponsor:** Brown University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-02
- **Primary completion:** 2011-03
- **Final completion:** 2016-12
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2022-03-08

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00828308

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00828308, "Neoadjuvant Weekly Ixabepilone for High Risk, Clinically Localized Prostate Cancer". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00828308. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*